Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
about
Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.Altered time structure of neuro-endocrine-immune system function in lung cancer patients.The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation.p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.Breast cancer: further metabolic-endocrine risk markers?The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies.Tumors of the endocrine/neuroendocrine system: an overview.Growth factors. Clinical implications in breast cancer.Insulin-like growth factor-I (IGF-I) receptors in breast cancer.Insulin-like growth factors in breast cancer.Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer.Type I insulin-like growth factor receptor function in breast cancer.IGF system components as prognostic markers in breast cancer.Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancersImmunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases.
P2860
Q33506131-DC052BD0-010A-4FDC-B54C-5F8929557930Q33611528-D7222E60-04EF-4463-BE3A-E497CDC62B83Q35063782-E5284727-D3F6-4BCC-83E5-B8F60C34D553Q35100621-E02E14D0-414E-4B13-A70B-FF8E1C4DEA33Q35552337-28EDDC22-D5A9-4050-A37C-B0F1A03447A7Q36235460-19423061-FD8F-41F9-B03A-6156E18D20DFQ36431629-5769A8AC-97F5-43FE-98E5-AE9CC87AB942Q36955067-40B23729-7455-40B8-84B0-AE447880A2C4Q37992693-C273A4EB-817C-4B72-98B5-27E902DD1279Q40623008-0A28187A-1BFD-4E75-B4E6-C8494DC33DC8Q40800342-FB255852-8C38-4E60-A7F2-3E54C4956521Q40999364-D864E3D3-5000-4C8F-8AE3-9AA10940215BQ41463854-23C8B13C-9F74-4A38-943C-4FE9C465CFD9Q41601838-A063962E-BD06-403A-9E6A-DB3C33F91C9FQ41727242-A69F47B0-B1B9-42C3-9D0D-07A379DFB206Q41727250-8604978E-3A49-407B-9BEE-9A35AA92906BQ41911846-D48CE319-E875-49DC-AFE9-84DF332AC225Q42050564-45F1B028-202D-4AC3-8E7D-AE1E0899550F
P2860
Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@ast
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@en
type
label
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@ast
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@en
prefLabel
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@ast
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@en
P2093
P1433
P1476
Insulin-like growth factor-1 r ...... n human primary breast cancer.
@en
P2093
P304
P356
10.1002/1097-0142(19890601)63:11<2139::AID-CNCR2820631112>3.0.CO;2-D
P407
P577
1989-06-01T00:00:00Z